RIL
WST icon

Rothschild Investment LLC’s West Pharmaceutical WST Stock Holding History

Rothschild Investment LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.4K Buy
93
+3
+3% +$917 ﹤0.01% 1360
2026
Q1 		$22.6K Sell
90
-630
-88% -$157K ﹤0.01% 1371
2025
Q4 		$198K Buy
720
+20
+3% +$5.47K 0.01% 626
2025
Q3 		$184K Buy
700
+637
+1,011% +$155K 0.01% 639
2025
Q2 		$13.8K Buy
63
+38
+152% +$8.12K ﹤0.01% 1127
2025
Q1 		$5.6K Sell
25
-31
-55% -$8.54K ﹤0.01% 1383
2024
Q4 		$18.3K Buy
56
+6
+12% +$1.89K ﹤0.01% 1019
2024
Q3 		$15K Buy
50
+37
+285% +$11.3K ﹤0.01% 1062
2024
Q2 		$4.28K Sell
13
-9
-41% -$3.18K ﹤0.01% 1230
2024
Q1 		$8.71K Buy
22
+5
+29% +$1.85K ﹤0.01% 1067
2023
Q4 		$5.99K Buy
+17
New +$6.02K ﹤0.01% 1060

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Rothschild Investment LLC's WST Position: Q2 2026 in Review

Rothschild Investment LLC increased its West Pharmaceutical (WST) stake by 3.3% in Q2 2026, buying an estimated $917 and bringing the position to 93 shares worth $33.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1360.

Rothschild Investment LLC first reported a position in WST in Q4 2023 and has held it in 11 quarters since. The position peaked at $198K in Q4 2025. 833 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Rothschild Investment LLC held 93 shares of West Pharmaceutical worth $33.4K as of Q2 2026.
  • Rothschild Investment LLC bought 3 West Pharmaceutical shares in Q2 2026, an estimated $917.
  • West Pharmaceutical made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1360 holding.
  • Rothschild Investment LLC first reported a position in West Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
  • Rothschild Investment LLC's West Pharmaceutical position peaked at $198K in Q4 2025.
  • 833 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.